A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from engineered B-cells in the immune system. . . . → Read More: Start-Up Developing Engineered B-Cell Therapies
|
|||||
|
       
  |
MD Anderson Cancer Center and Allogene Therapeutics Inc. agreed to jointly study the company’s cancer treatments derived from donated T-cells. . . . → Read More: Cancer Center, Biotech Partner on Off-the-Shelf T-Cells 
A biotechnology company creating synthetic viruses with artificial intelligence to deliver gene therapies is licensing its technology to drug maker Roche. . . . → Read More: Gene Therapy Delivery Tech Licensed in $1.8B Deal 
A new technology makes possible simultaneous analysis of diagnostic specimens from thousands of individuals revealing the presence of SARS-CoV-2 coronaviruses. . . . → Read More: Process Tests Thousands of Covid-19 Samples at Once 
The U.S. Defense Department’s research agency is funding a prototype mobile lab to produce RNA-based vaccines and therapies in the field on demand. . . . → Read More: DoD Funding Mobile Vaccine/Therapy Manufacturing Lab  Comments are closed  Finance  biomedical, biotechnology, cancer, Covid-19, DoD, engineering, genomics, grant, life sciences, manufacturing, pharmaceuticals 
A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors. . . . → Read More: New Company IDs Drugs Targeting Cancer Cell Networks One comment - (Comments are closed) Finance biomedical, biotechnology, Canada, cancer, engineering, entrepreneurs, equity, genomics, investment, life sciences, mathematics, pharmaceuticals, physical sciences, venture capital 
A new enterprise is underway developing therapeutics targeting bacterial communities in the body, to treat metabolic disorders and cancer. . . . → Read More: Microbiome Therapies Company Unveils, Raises $50M Comments are closed Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, university, venture capital 
A company developing precision medicine drugs to treat inherited heart disorders was acquired by drug maker Bristol Myers Squibb, or BMS, for $13.1 billion. . . . → Read More: Heart Disease Biotech Acquired in $13.1B Deal Comments are closed Finance biomedical, biotechnology, clinical trials, entrepreneurs, equity, genomics, heart disease, investment, life sciences, merger, pharmaceuticals 
A biotechnology company and genomics data science enterprise agreed in a multi-year agreement to discover new therapies for up to 20 diseases. . . . → Read More: Biotech, Analytics Companies Partner on Drug Discovery One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, engineering, genomics, life sciences, mathematics, pharmaceuticals, physical sciences 
A biotechnology company is developing biologic treatments for Covid-19 infections in the gastrointestinal tract and to block further disease transmission. . . . → Read More: DoD Funds Covid-19 G.I. Infection Therapy Comments are closed Finance, New products biomedical, biotechnology, Covid-19, DoD, genomics, grant, life sciences, manufacturing, pharmaceuticals |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||